Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion

Brain Pathology

Volumn 28, Issue 4, 2018, Pages 521-535

  Uemura, Maiko T ^a   Ihara, Masafumi ^b   Maki, Takakuni ^a   Nakagomi, Takayuki ^c   Kaji, Seiji ^a   Uemura, Kengo ^d   Matsuyama, Tomohiro ^c   Kalaria, Raj N ^e   Kinoshita, Ayae ^a   Takahashi, Ryosuke ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Ishiki Hospital   (Japan)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; GLUCOSE; NOGGIN; OSTEOGENIC PROTEIN 1; OXYGEN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA1; BMP4 PROTEIN, HUMAN; CARRIER PROTEIN; NOGGIN PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN CELL CULTURE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN PERICYTE; CAROTID ARTERY OBSTRUCTION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; UPREGULATION; VERY ELDERLY; WHITE MATTER INJURY; ANIMAL; BRAIN; CELL CULTURE; METABOLISM; MYELIN SHEATH; PATHOLOGY; PERICYTE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BRAIN; CARRIER PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; MICE; MYELIN SHEATH; PERICYTES; WHITE MATTER;

EID: 85020019193     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12523     Document Type: Article

References (59)

1. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H (1998) Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol 95:78–84.
2. American Psychiatric, Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
3. Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB (2008) Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res 86:125–135.
4. Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber EN et al (2011) White matter lesions defined by diffusion tensor imaging in older adults. Ann Neurol 70:465–476.
5. Bennett DA, Wilson RS, Gilley DW, Fox JH (1990) Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 53:961–965.
6. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404.
7. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259.
8. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR (2007) Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2:1044–1051.
9. Choi JC (2015) Genetics of cerebral small vessel disease. J Stroke 17:7–16.
10. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ (2012) Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther 4:1.
11. Craggs LJ, Fenwick R, Oakley AE, Ihara M, Kalaria RN (2015) Immunolocalization of platelet-derived growth factor receptor-beta (PDGFR-beta) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neuropathol Appl Neurobiol 41:557–570.
12. Dizon ML, Maa T, Kessler JA (2011) The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiol Dis 42:318–326.
13. Erkinjuntti T, Benavente O, Eliasziw M, Munoz DG, Sulkava R, Haltia M, Hachinski V (1996) Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 53:325–332.
14. Fuller ML, DeChant AK, Rothstein B, Caprariello A, Wang R, Hall AK, Miller RH (2007) Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 62:288–300.
15. Gomes WA, Mehler MF, Kessler JA (2003) Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255:164–177.
16. Grinspan JB, Edell E, Carpio DF, Beesley JS, Lavy L, Pleasure D, Golden JA (2000) Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage. J Neurobiol 43:1–17.
17. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17:595–606.
18. Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A et al (2009) Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 360:1729–1739.
19. Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80:844–866.
20. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE et al (2010) Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 119:579–589.
21. Ihara M, Yamamoto Y (2016) Emerging evidence for pathogenesis of sporadic cerebral small vessel disease. Stroke 47:554–560.
22. Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113:349–388.
23. Jellinger KA (2013) Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci 5:17.
24. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T (2004) Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 226:75–80.
25. Kamouchi M, Ago T, Kuroda J, Kitazono T (2012) The possible roles of brain pericytes in brain ischemia and stroke. Cell Mol Neurobiol 32:159–165.
26. Kan L, Kitterman JA, Procissi D, Chakkalakal S, Peng CY, McGuire TL et al (2012) CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol 259:2644–2655.
27. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA (1997) Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J Neurosci 17:4112–4120.
28. Maesako M, Uemura M, Tashiro Y, Sasaki K, Watanabe K, Noda Y et al (2015) High fat diet enhances beta-site cleavage of amyloid precursor protein (APP) via promoting beta-site APP cleaving enzyme 1/adaptor protein 2/clathrin complex formation. PLoS One 10:e0131199.
29. Maki T, Ihara M, Fujita Y, Nambu T, Miyashita K, Yamada M et al (2011) Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice. Stroke 42:1122–1128.
30. Maki T, Maeda M, Uemura M, Lo EK, Terasaki Y, Liang AC et al (2015) Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter. Neurosci Lett 597:164–169.
31. Mazaheri Z, Movahedin M, Rahbarizadeh F, Amanpour S (2011) Different doses of bone morphogenetic protein 4 promote the expression of early germ cell-specific gene in bone marrow mesenchymal stem cells. In Vitro Cell Dev Biol Anim 47:521–525.
32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486.
33. Miyamoto N, Tanaka R, Shimura H, Watanabe T, Mori H, Onodera M et al (2010) Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab 30:299–310.
34. Nicolakakis N, Hamel E (2011) Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab 31:1354–1370.
35. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y et al (2012) Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 123:381–394.
36. Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB (2012) Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol 71:640–653.
37. Renner O, Tsimpas A, Kostin S, Valable S, Petit E, Schaper W, Marti HH (2003) Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. Brain Res Mol Brain Res 113:44–51.
38. Ronnemaa E, Zethelius B, Lannfelt L, Kilander L (2011) Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 31:460–466.
39. Rosenberg GA, Wallin A, Wardlaw JM, Markus HS, Montaner J, Wolfson L et al (2016) Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab 36:6–25.
40. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57:789–794.
41. Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld FM et al (2015) Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun 6:7677.
42. Sabo JK, Aumann TD, Kilpatrick TJ, Cate HS (2013) Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair. PLoS One 8:e63415.
43. Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS (2011) Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J Neurosci 31:4504–4510.
44. Samanta J, Alden T, Gobeske K, Kan L, Kessler JA (2010) Noggin protects against ischemic brain injury in rodents. Stroke 41:357–362.
45. See JM, Grinspan JB (2009) Sending mixed signals: bone morphogenetic protein in myelination and demyelination. J Neuropathol Exp Neurol 68:595–604.
46. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV (2013) Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 23:303–310.
47. Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K et al (2014) Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-beta signaling. PLoS One 9:e103174.
48. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35:2598–2603.
49. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35.
50. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G (2005) PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870–879.
51. Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19:771–783.
52. Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P (2006) Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis 10:111–118.
53. Vicente Lopez MA, Vazquez Garcia MN, Entrena A, Olmedillas Lopez S, Garcia-Arranz M, Garcia-Olmo D, Zapata A (2011) Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. Stem Cells Dev 20:1011–1019.
54. Wardlaw JM, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12:483–497.
55. Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14:1398–1405.
56. Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV (2013) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125:111–120.
57. Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J et al (2012) Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci 32:6651–6664.
58. Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T et al (2009) Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 40:2004–2011.
59. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12:723–738.